Swiss-based Distalmotion announced the closing of a $90 million series E financing to support the global commercialization of its surgical robot Dexter.
Specialist investor Revival Healthcare Capital’s president and chairman explain to AltAssets how finding their own gap in the market led to a booming second fund close.